BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao X, AbdelKhalek A, Abutaleb NS, Velagapudi UK, Yoganathan S, Seleem MN, Talele TT. Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors. J Med Chem 2019;62:9772-91. [PMID: 31584822 DOI: 10.1021/acs.jmedchem.9b01198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hao S, Yang J, Liu P, Xu J, Yang C, Li F. Linear-Organic-Polymer-Supported Iridium Complex as a Recyclable Auto-Tandem Catalyst for the Synthesis of Quinazolinones via Selective Hydration/Acceptorless Dehydrogenative Coupling from o-Aminobenzonitriles. Org Lett 2021;23:2553-8. [PMID: 33729807 DOI: 10.1021/acs.orglett.1c00475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
2 Naclerio GA, Abutaleb NS, Li D, Seleem MN, Sintim HO. Ultrapotent Inhibitor of Clostridioides difficile Growth, Which Suppresses Recurrence In Vivo. J Med Chem 2020;63:11934-44. [PMID: 32960605 DOI: 10.1021/acs.jmedchem.0c01198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Fisher JF, Mobashery S. β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium. Chem Rev 2021;121:3412-63. [PMID: 33373523 DOI: 10.1021/acs.chemrev.0c01010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rahmani Khajouei M, Khodarahmi G, Ghaderi A. Synthesis and cytotoxic evaluation of some novel 3-[2-(2-phenyl-thiazol-4-yl)-ethyl]-3H-pyrido[2,3-d]pyrimidin-4-one derivatives. Res Pharm Sci 2021;16:455-63. [PMID: 34522193 DOI: 10.4103/1735-5362.323912] [Reference Citation Analysis]
5 Chang M, Mahasenan KV, Hermoso JA, Mobashery S. Unconventional Antibacterials and Adjuvants. Acc Chem Res 2021;54:917-29. [PMID: 33512995 DOI: 10.1021/acs.accounts.0c00776] [Reference Citation Analysis]
6 Abutaleb NS, Seleem MN. Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections. Antimicrob Agents Chemother 2020;64:e02115-19. [PMID: 32253206 DOI: 10.1128/AAC.02115-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
7 Talele TT. Acetylene Group, Friend or Foe in Medicinal Chemistry. J Med Chem 2020;63:5625-63. [PMID: 32031378 DOI: 10.1021/acs.jmedchem.9b01617] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
8 Lagardère P, Fersing C, Masurier N, Lisowski V. Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals (Basel) 2021;15:35. [PMID: 35056092 DOI: 10.3390/ph15010035] [Reference Citation Analysis]
9 Pal R, Dai M, Seleem MN. High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro. Sci Rep 2021;11:10913. [PMID: 34035338 DOI: 10.1038/s41598-021-90314-3] [Reference Citation Analysis]